Remove 2023 Remove Pharma Remove Prescription
article thumbnail

Bill that would cut down ‘patent thickets’ clears Senate

pharmaphorum

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.Lawmakers unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S-150), which is part of a lengthening list of measures being taken by Congress to curb the (..)

article thumbnail

'The Top Line': A special episode on Narcan, the life-saving nasal spray

Fierce Pharma

In this episode of 'The Top Line' we replay an important show from April 28, 2023 regarding Narcan. | This week on "The Top Line," we revisit an episode on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

And in 2023, these investments will hopefully pay off. In 2023, omnichannel behaviours will directly influence incentive compensation models by correlating successful engagement data to successful sales outcomes. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.

Marketing 106
article thumbnail

Pharma USA 2023 | March 28–29, 2023

Pharma Marketing Network

Join Reuters Events’ exclusive panel discussion to hear experts from Novartis, Takeda and Janssen share business-critical learnings, including: Differentiate predictive vs prescriptive insights and inform your next best action. The post Pharma USA 2023 | March 28–29, 2023 appeared first on Pharma Marketing Network.

Pharma 52
article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

article thumbnail

Pharma USA 2023: Digital Therapeutics and Pharma

PharmExec

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Pharma 52
article thumbnail

AbbVie sucks

World of DTC Marketing

The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The executives at AbbVie make over $300 million.